Charles Sermon serves as Executive at Mereo BioPharma Group plc, where they oversee executive responsibilities. Since joining the company, Charles Sermon has executed 6 insider transactions totaling $294.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 13, 2024 involved selling 20,946 shares valued at $88.4K.
Charles Sermon currently holds 219,061 shares of Mereo BioPharma Group plc (MREO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Sermon has been a net seller of MREO stock. They have purchased $0 and sold $294.5K worth of shares.
Charles Sermon's most recent insider trade was on Sep 13, 2024, when they sold 20,946 shares at $4.22 per share.
Get notified when new Form 4 filings are submitted
| $4.47 |
| Discretionary |
| Sep 11, 2024 | MREO | $0 | Option Exercise | 65,600 | $N/A | Discretionary |
| Jun 26, 2024 | MREO | $109.1K | Sale | 32,187 | $3.39 | Discretionary |
| Jun 25, 2024 | MREO | $52.4K | Sale | 14,202 | $3.69 | Discretionary |
| Jun 21, 2024 | MREO | $0 | Option Exercise | 98,400 | $N/A | Discretionary |